Filtered By:
Condition: ADHD

This page shows you your search results in order of date. This is page number 11.

Order by Relevance | Date

Total 184 results found since Jan 2013.

Neuroimmune Crosstalk in CNS Disorders: The Histamine Connection.
Abstract The neuroimmune system represents a dense network of biochemical signals associated with neurotransmitters, neuropeptides, neurohormones, cytokines, chemokines, and growth factors synthesized in neurons, glial cells and immune cells, to maintain systemic homeostasis. Endogenous and/or exogenous, noxious stimuli in any tissue are captured by sensor cells to inform the brain; likewise, signals originating at the central nervous system (CNS) level are transmitted to peripheral immune effectors which react to central stimuli. This multidirectional information system makes it possible for the CNS to respond to...
Source: Current Pharmaceutical Design - December 9, 2015 Category: Drugs & Pharmacology Authors: Cacabelos R, Torrellas C, Fernández-Novoa L, Aliev G Tags: Curr Pharm Des Source Type: research

Probable Nootropic-induced Psychiatric Adverse Effects: A Series of Four Cases
Conclusion Healthcare providers in general, and specifically those in the mental health and substance abuse fields, should keep in mind that nootropic use is an under recognized and evolving problem. Nootropic use should be considered in cases where there are sudden or unexplained exacerbations of psychiatric symptoms in patients who have been stable and medication adherent. It is also important to remember that most nootropics are not detected on standard drug toxicology screening tests. We have very little clinical information on how nootropics may interact with psychotropics (or other medications) and potentially cause ...
Source: Innovations in Clinical Neuroscience - December 1, 2015 Category: Neuroscience Authors: ICN Online Editor Tags: Case Series and Literature Review Current Issue Mental Disorders Psychiatry Psychopharmacology Substance Use Disorders Ampakines Armodafinil brain enhancer Cerebrolysin Citicoline cognitive enhancer homeopathic medicine natural r Source Type: research

Electroencephalographic neurofeedback: Level of evidence in mental and brain disorders and suggestions for good clinical practice
Publication date: Available online 6 November 2015 Source:Neurophysiologie Clinique/Clinical Neurophysiology Author(s): J.-A. Micoulaud-Franchi, A. McGonigal, R. Lopez, C. Daudet, I. Kotwas, F. Bartolomei The technique of electroencephalographic neurofeedback (EEG NF) emerged in the 1970s and is a technique that measures a subject's EEG signal, processes it in real time, extracts a parameter of interest and presents this information in visual or auditory form. The goal is to effectuate a behavioural modification by modulating brain activity. The EEG NF opens new therapeutic possibilities in the fields of psychiat...
Source: Neurophysiologie Clinique - November 10, 2015 Category: Neuroscience Source Type: research

Study in mice shows how brain ignores distractions
In a study of mice, scientists discovered that a brain region called the thalamus may be critical for filtering out distractions. The study, published in Nature and partially funded by the National Institutes of Health, paves the way to understanding how defects in the thalamus might underlie symptoms seen in patients with autism, attention deficit hyperactivity disorder (ADHD), and schizophrenia.
Source: NINDS Press Releases and News: National Institute of Neurological Disorders and Stroke - October 21, 2015 Category: Neurology Source Type: news

Autism in the Son of a Woman with Mitochondrial Myopathy and Dysautonomia: A Case Report
Conclusion Given emerging evidence that mitochondrial dysfunction, particularly in the electron transport chain needed for cellular energy production, is an underlying pathophysiological mechanism for some varieties of ASD, clinicians should have a high index of suspicion for mitochondrial disease, especially when they encounter a patient with unusual neurological or constitutional symptoms. The prevalence of mitochondrial disease in ASD patients may be as high as five percent, which means that it is not the “zebra”[27] diagnosis that it might be in a non-ASD patient, where prevalence is about 0.01 percent.10 Reference...
Source: Innovations in Clinical Neuroscience - October 9, 2015 Category: Neuroscience Authors: ICN Online Editor Tags: Anxiety Disorders Asperger's syndrome Autism Behavioral and Cognitive Neurology Case Report Current Issue Intellectual Disability Neurologic Systems and Symptoms Pervasive Developmental Disorders ASD autism spectrum disorder dysauton Source Type: research

Invisible Illness or Chronic Illness? What's the Difference?
Why do we say we have an "invisible illness"? Is is because we feel invisible to people? Years ago the term "invisible illness" was rarely used. Before social media the opportunity to talk about your disease was relegated to a local support group and perhaps a caring friend or two. Illness was something you spoke to your doctor about... and that was all. I became an online illness advocate when I built my first website for those with chronic illness in 1996. As the Internet has evolved from news groups to social media, much has changed. But I have seen one continual thread: people are eager to share about their illness exp...
Source: Healthy Living - The Huffington Post - September 23, 2015 Category: Consumer Health News Source Type: news

Bilateral Uterine Artery Ligation (BUAL): Placental Insufficiency Causing Fetal Growth Restriction and Cerebral Palsy
Placental insufficiency is the leading cause of intrauterine growth restriction in the western world. The fetus, when exposed to a compromised environment, is vulnerable to a number of disorders later in life, as a consequence of the reduction in oxygen and nutrition during gestation and the resulting fetal growth restriction. These conditions include neurological disabilities such as cerebral palsy (CP), intellectual disability, epilepsy, and mental health issues in childhood (Autism and ADHD) and in later life (schizophrenia). Certainly, fetal growth restriction as a result of placental insufficiency has been strongly as...
Source: Springer protocols feed by Neuroscience - September 21, 2015 Category: Neuroscience Source Type: news

Brief Report: Forecasting the Economic Burden of Autism in 2015 and 2025 in the United States.
Abstract Few US estimates of the economic burden of autism spectrum disorders (ASD) are available and none provide estimates for 2015 and 2025. We forecast annual direct medical, direct non-medical, and productivity costs combined will be $268 billion (range $162-$367 billion; 0.884-2.009 % of GDP) for 2015 and $461 billion (range $276-$1011 billion; 0.982-3.600 % of GDP) for 2025. These 2015 figures are on a par with recent estimates for diabetes and attention deficit and hyperactivity disorder (ADHD) and exceed the costs of stroke and hypertension. If the prevalence of ASD continues to grow as it has in recent...
Source: Journal of Autism and Developmental Disorders - July 17, 2015 Category: Psychiatry Authors: Leigh JP, Du J Tags: J Autism Dev Disord Source Type: research

Genetic analysis of genes causing hypertension and stroke in spontaneously hypertensive rats: Gene expression profiles in the kidneys.
Abstract Spontaneously hypertensive rats (SHRs) and stroke-prone SHRs (SHRSP) are frequently used as models not only of essential hypertension and stroke, but also of attention-deficit hyperactivity disorder (ADHD). Normotensive Wistar-Kyoto (WKY) rats are normally used as controls in these studies. In the present study, we aimed to identify the genes causing hypertension and stroke, as well as the genes involved in ADHD using these rats. We previously analyzed gene expression profiles in the adrenal glands and brain. Since the kidneys can directly influence the functions of the cardiovascular, endocrine and sy...
Source: International Journal of Molecular Medicine - July 10, 2015 Category: Molecular Biology Authors: Watanabe Y, Yoshida M, Yamanishi K, Yamamoto H, Okuzaki D, Nojima H, Yasunaga T, Okamura H, Matsunaga H, Yamanishi H Tags: Int J Mol Med Source Type: research

Inflammatory Claims About Inflammation
We all appreciate the elegance of simple solutions to complex problems. But we know too that simplicity can often masquerade as truth, hiding a more nuanced reality. Such is the case with inflammation, where pseudoscience, exaggerated claims, false promises, and dangerous oversimplification have dominated for too long. Here is a typical missive: "Inflammation controls our lives. Have you or a loved one dealt with pain, obesity, ADD/ADHD, peripheral neuropathy, diabetes, heart disease, stroke, migraines, thyroid issues, dental issues, or cancer? If you answered yes to any of these disorders you are dealing with inflammatio...
Source: Science - The Huffington Post - May 29, 2015 Category: Science Source Type: news

No such thing as baby brain, study argues
Conclusion The researchers conclude that although the pregnant women reported memory problems, these did not show up on their tests. However, this does not take into account their pre-pregnancy ability. The women may have performed better before they got pregnant, which is why they are now reporting memory problems. None of these women were tested before they got pregnant, which is the major limitation of the study. The researchers say that because there were a similar number of students in each group, the women in the control group was a good enough representation of how the pregnant women would have performed pre-pregna...
Source: NHS News Feed - April 8, 2015 Category: Consumer Health News Tags: Mental health Neurology Pregnancy/child Source Type: news

Assessment of potential cardiovascular risks of methylphenidate in comparison with sibutramine: do we need a SCOUT (trial)?
Abstract With the recent approval of methylphenidate (MPH) for treating attention-deficit/hyperactivity disorder (ADHD) in adults, the number of patients exposed will increase tremendously. The ongoing debate on the cardiovascular safety of MPH has triggered two large retrospective cohort studies in children and adolescents as well as in young to middle-aged adults. These studies looked into serious cardiovascular events (sudden cardiac death, acute myocardial infarction and stroke) as primary endpoints and concluded that MPH was safe after a mean duration of 2.1 years of follow-up in children and adolescent...
Source: European Archives of Psychiatry and Clinical Neuroscience - March 17, 2015 Category: Neuroscience Source Type: research

The Neuroprotective Potential of Low-Dose Methamphetamine in Preclinical Models of Stroke and Traumatic Brain Injury
Publication date: Available online 25 February 2015 Source:Progress in Neuro-Psychopharmacology and Biological Psychiatry Author(s): Thomas Rau , John Ziemniak , David Poulsen Methamphetamine is a psychostimulant that was initially synthesized in 1920. Since then it has been used to treat attention deficit hyperactive disorder (ADHD), obesity and narcolepsy. However, methamphetamine has also become a major drug of abuse worldwide. Under conditions of abuse, which involve the administration of high repetitive doses, methamphetamine can produce considerable neurotoxic effects. However, recent evidence from our laboratory i...
Source: Progress in Neuro Psychopharmacology and Biological Psychiatry - February 25, 2015 Category: Psychiatry Source Type: research

Resting-state sensorimotor rhythm (SMR) power predicts the ability to up-regulate SMR in an EEG-instrumental conditioning paradigm
During instrumental conditioning of EEG activity (EEG-IC), participants receive feedback of a specific aspect of their brain signals (Lubar et al., 1995), e.g. feedback on the power of a certain frequency band. Desired patterns of EEG activity are rewarded by visual or auditory stimuli, thus enabling participants to modulate their brain activity by means of instrumental conditioning. EEG-IC training has been used to treat patients with disorders such as epilepsy (Sterman and Egner, 2006), attention deficit hyperactivity disorder (Arns et al., 2009) and stroke (Doppelmayr et al., 2007), as well as in healthy participants (H...
Source: Clinical Neurophysiology - February 6, 2015 Category: Neuroscience Authors: Johanna Louise Reichert, Silvia Erika Kober, Christa Neuper, Guilherme Wood Source Type: research